BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 30262723)

  • 1. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as potential investigative and predictive biomarkers in colorectal cancer.
    Yaghoubi N; Zahedi Avval F; Khazaei M; Aghaee-Bakhtiari SH
    Cell Signal; 2021 Apr; 80():109910. PubMed ID: 33387618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of miRNAs in colorectal cancer progression and chemoradiotherapy.
    Zhang N; Hu X; Du Y; Du J
    Biomed Pharmacother; 2021 Feb; 134():111099. PubMed ID: 33338745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
    Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
    BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
    Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
    BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
    Moridikia A; Mirzaei H; Sahebkar A; Salimian J
    J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
    Tang XJ; Wang W; Hann SS
    Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases.
    Balacescu O; Sur D; Cainap C; Visan S; Cruceriu D; Manzat-Saplacan R; Muresan MS; Balacescu L; Lisencu C; Irimie A
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: relevant tools for a colorectal surgeon?
    Peacock O; Lee AC; Larvin M; Tufarelli C; Lund JN
    World J Surg; 2012 Aug; 36(8):1881-92. PubMed ID: 22526047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNAs in colorectal cancer.
    Mohammadi A; Mansoori B; Baradaran B
    Biomed Pharmacother; 2016 Dec; 84():705-713. PubMed ID: 27701052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate microRNA biomarkers in human colorectal cancer: systematic review profiling studies and experimental validation.
    Ma Y; Zhang P; Yang J; Liu Z; Yang Z; Qin H
    Int J Cancer; 2012 May; 130(9):2077-87. PubMed ID: 21671476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.